Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aviragen Therapeutics Inc (NASDAQ:AVIR)

1.62
Delayed Data
As of May 23
 +0.02 / +1.25%
Today’s Change
1.23
Today|||52-Week Range
2.66
-16.49%
Year-to-Date
No recent news for Aviragen Therapeutics Inc.

Today’s Trading

Previous close1.60
Today’s open1.62
Day’s range1.61 - 1.64
Volume3,509
Average volume (3 months)37,619
Market cap$61.8M
Dividend yield--
Data as of 05/23/2016

Growth & Valuation

Earnings growth (last year)-54.29%
Earnings growth (this year)+59.26%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-64.19%
P/E ratioNM
Price/Sales2.98
Price/Book0.89

Competitors

 Today’s
change
Today’s
% change
CERUCerulean Pharma Inc+0.04+1.74%
REPHRecro Pharma Inc+0.06+0.95%
CAPRCapricor Therapeutic...-0.03-1.01%
OREXOrexigen Therapeutic...+0.01+2.65%
Data as of 05/23/2016

Financials

Next reporting dateSeptember 9, 2016
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$24.6M
Annual profit (last year)-$19.1M
Net profit margin-77.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Joseph M. Patti
Chief Financial Officer &
Executive Vice President
Mark P. Colonnese
Corporate headquarters
Alpharetta, Georgia

Forecasts

Partner Offers

Search for Jobs